World Evidence, Pricing and Access Congress is Europe’s largest congress in market access, pricing and evidence featuring 300 speakers, 8 tracks and 1500+ attendees from pharma, biotech and Payers/HTAs. The 2025 edition will now take place over 2 days, introducing the Health Economics & Outcomes Research track and a poster area to bring more academic presence at EPA, more content and depth to the discussion. We will also be strengthening our core topic areas which include Market Access and Pricing, Rare Diseases, HTA/Payer and Evidence by covering the latest trends in reimbursement, payment models, affordability, HEOR and many other developments within the industry
